Tibet Rhodiola Pharmaceutical Holding Co.SSE: 600211

Announcement on Obtaining Approval Notice for Drug Supplement Application by Wholly-Owned Subsidiary

· Issued by Tibet Rhodiola Pharmaceutical Holding Co. via Shanghai Stock Exchange

Filed with SSE · · 2 pages · Chinese

Release

Announcement on Obtaining Approval Notice for Drug Supplement Application by Wholly-Owned Subsidiary

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

Tibet Rhodiola Pharmaceutical Holding Co. on 6ix

Earlier from Tibet Rhodiola Pharmaceutical

Later from Tibet Rhodiola Pharmaceutical

All Tibet Rhodiola Pharmaceutical news releases